These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6492089)

  • 1. Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.
    Collipp PJ; Kelemen J; Chen SY; Castro-Magana M; Angulo M; Derenoncourt A
    J Med Genet; 1984 Aug; 21(4):254-6. PubMed ID: 6492089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
    Zatz M; Betti RT; Frota-Pessoa O
    Am J Med Genet; 1986 Jul; 24(3):549-66. PubMed ID: 3524231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
    Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mazindol and growth hormone inhibition in Duchenne muscular dystrophy.
    Zatz M; Vainzof M; Rapaport D; da Rocha JM; Pavanello Rde C; Betti RT
    Am J Med Genet; 1987 Aug; 27(4):993-5. PubMed ID: 3321999
    [No Abstract]   [Full Text] [Related]  

  • 5. Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
    Zatz M; Rapaport D; Pavanello RC; Rocha JM; Vainzof M; Nicolau W
    Am J Med Genet; 1989 Aug; 33(4):457-67. PubMed ID: 2596504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mazindol on growth hormone levels in patients with Duchenne muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Pavanello Rde C; Rocha JM; Betti RT; Otto PA
    Am J Med Genet; 1988 Dec; 31(4):821-33. PubMed ID: 3239574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol in Duchenne muscular dystrophy.
    Coakley JH; Edwards RH; Moorcraft J; Hipkin LJ; Smith CS
    Lancet; 1988 Jan; 1(8578):184. PubMed ID: 2893022
    [No Abstract]   [Full Text] [Related]  

  • 8. Selenium metabolism and supplementation in patients with muscular dystrophy.
    Jackson MJ; Coakley J; Stokes M; Edwards RH; Oster O
    Neurology; 1989 May; 39(5):655-9. PubMed ID: 2540451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind trial of mazindol in Duchenne dystrophy.
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Miller PJ; Mandel S; Florence J; Schierbecker J; Kaiser KK
    Muscle Nerve; 1990 Dec; 13(12):1169-73. PubMed ID: 2266990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy.
    Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006
    [No Abstract]   [Full Text] [Related]  

  • 11. Height and clinical course of Duchenne muscular dystrophy.
    Coakley JH; Griffiths RD; Edwards RH
    Am J Med Genet; 1989 Apr; 32(4):552-4. PubMed ID: 2774003
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone evaluation in Duchenne muscular dystrophy.
    Merlini L; Granata C; Ballestrazzi A; Cornelio F; Tassoni P; Tugnoli S; Cacciari E
    Ital J Neurol Sci; 1988 Oct; 9(5):471-5. PubMed ID: 3215748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a growth hormone inhibitor on the course of Duchenne's myopathy].
    Serratrice G; Desnuelle C
    Presse Med; 1988 Nov; 17(41):2201. PubMed ID: 2974583
    [No Abstract]   [Full Text] [Related]  

  • 14. Selenium supplementation in X-linked muscular dystrophy. Effects on erythrocyte and serum selenium and on erythrocyte glutathione peroxidase activity.
    Gebre-Medhin M; Gustavson KH; Gamstorp I; Plantin LO
    Acta Paediatr Scand; 1985 Nov; 74(6):886-90. PubMed ID: 4090964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.
    Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    J Clin Invest; 1972 May; 51(5):1118-24. PubMed ID: 5057128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selenium and vitamin E in patients with progressive muscular dystrophy].
    Voirin J; Deschrevel G; Guincestre JY; Foucault P; Bureau F; Duhamel JF
    Ann Pediatr (Paris); 1990 Jun; 37(6):377-9. PubMed ID: 2400191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.
    Bäckman E; Nylander E; Johansson I; Henriksson KG; Tagesson C
    Acta Neurol Scand; 1988 Nov; 78(5):429-35. PubMed ID: 3218450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral zinc supplements on growth, hormonal levels, and zinc in healthy short children.
    Ghavami-Maibodi SZ; Collipp PJ; Castro-Magana M; Stewart C; Chen SY
    Ann Nutr Metab; 1983; 27(3):214-9. PubMed ID: 6683093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suggestion for a possible mitigating treatment of Duchenne muscular dystrophy.
    Zatz M; Frota-Pessoa O
    Am J Med Genet; 1981; 10(3):305-7. PubMed ID: 7304675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.